IDEX Biometrics ASA - Director's Dealing 2017

Mandatory notification of trades in IDEX

On 9 August 2017, the following primary insiders were granted subscription

rights under the company's 2017 incentive subscription rights plan:

CEO Dr. Hemant Mardia was granted 580,000 subscription rights. Following the

grant, Dr. Mardia and his close associates hold or control 2,115,625 shares and

3,830,000 subscription rights in IDEX.

CFO Henrik Knudtzon was granted 415,000 subscription rights. Following the

grant, Mr. Knudtzon holds or controls 0 (nil) shares and 2,290,000 subscription

rights in IDEX.

Chief Products Officer, Stan Swearingen was granted 415,000 subscription rights.

Following the grant, Mr. Swearingen holds or controls 0 (nil) shares and

2,315,000 subscription rights in IDEX.

VP Finance & Accounting, Erling Svela was granted 90,000 subscription rights.

Following the grant, Mr. Svela holds or controls 230,167 shares and 90,000

subscription rights in IDEX.

Charlotte Knudsen, Director of IR and Communications, was granted 75,000

subscription rights. Following the grant, Ms. Knudsen holds or controls 0 (nil)

shares and 75,000 subscription rights in IDEX.

The exercise price of the subscription rights is NOK 7.76 per share. 25 per cent

of the subscription rights vest per year from the date of the grant. The

subscription rights expire on 9 August 2021.

This information is subject to the disclosure requirements pursuant to section

5-12 of the Norwegian Securities Trading Act.

AI assistant